Literature DB >> 1233223

The protein binding of some drugs in plasma from patients with alcoholic liver disease.

M Affrime, M M Reidenberg.   

Abstract

The binding of 5 drugs to plasma proteins from patients with alcoholic liver disease has been studied by in vitro techniques and compared to that from normal subjects. The binding of quinidine is decreased in such patients. For this reason, if in patients with alcoholic liver disease treated for coincidental arrhythmias with quinidine, plasma quinidine concentrations are measured, allowance for the decreased binding must be made in interpreting the concentration measurements. Diphenylhydantoin binding was normal or near normal in most of the patients' plasma samples. The other drugs tested, fluorescein, dapsone, and triamterene, had decreased binding in the patients' plasma samples.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1233223     DOI: 10.1007/bf00567126

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  9 in total

1.  Plasma protein binding of diphenylhydantoin in man. Interaction with other drugs and the effect of temperature and plasma dilution.

Authors:  P K Lunde; A Rane; S J Yaffe; L Lund; F Sjöqvist
Journal:  Clin Pharmacol Ther       Date:  1970 Nov-Dec       Impact factor: 6.875

2.  Biologically active androgens and oestradiol in men with chronic liver disease.

Authors:  A Galvão-Teles; C W Burke; D C Anderson; J C Marshall; C S Corker; R L Bown; M L Clark
Journal:  Lancet       Date:  1973-01-27       Impact factor: 79.321

3.  Influence of disease on binding of drugs to plasma proteins.

Authors:  M M Reidenberg; M Affrime
Journal:  Ann N Y Acad Sci       Date:  1973-11-26       Impact factor: 5.691

4.  Effect of protein binding on the distribution of 5,5-diphenylhydantoin between plasma and red cells.

Authors:  P Borondy; W A Dill; T Chang; R A Buchanan; A J Glazko
Journal:  Ann N Y Acad Sci       Date:  1973-11-26       Impact factor: 5.691

5.  Plasma protein binding of diphenylhydantoin. Effects of sex hormones, renal and hepatic disease.

Authors:  W D Hooper; F Bochner; M J Eadie; J H Tyrer
Journal:  Clin Pharmacol Ther       Date:  1974-03       Impact factor: 6.875

6.  The simultaneous determination of multiple anticonvulsant drug levels by gas-liquid chromatography. Method and clinical application.

Authors:  E B Solow; J B Green
Journal:  Neurology       Date:  1972-05       Impact factor: 9.910

7.  Drug therapy. Serum drug concentrations as therapeutic guides.

Authors:  J Koch-Weser
Journal:  N Engl J Med       Date:  1972-08-03       Impact factor: 91.245

8.  [Binding of testosterone and estradiol-17beta by serum proteins in normal persons and in patients with liver cirrhosis].

Authors:  J Breuer; H T Schneider; H Breuer
Journal:  Z Klin Chem Klin Biochem       Date:  1970-11

9.  Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma protein binding.

Authors:  L W Powell; E Axelsen
Journal:  Gut       Date:  1972-09       Impact factor: 23.059

  9 in total
  22 in total

Review 1.  Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).

Authors:  R Zini; P Riant; J Barré; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

2.  Decreased drug binding in serum from patients with chronic hepatic disease.

Authors:  S Wallace; M J Brodie
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

3.  Effect of halofenate on the serum binding of phenytoin.

Authors:  F E Karch; W M Wardell; M Dambly; A Gringeri
Journal:  Br J Clin Pharmacol       Date:  1977-10       Impact factor: 4.335

4.  [Pharmaco-kinetic aspects of protein-binding (author's transl)].

Authors:  H Kurz
Journal:  Klin Wochenschr       Date:  1978-12-15

5.  Pharmacokinetics of quinidine in male patients. A population analysis.

Authors:  C N Verme; T M Ludden; W A Clementi; S C Harris
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

Review 6.  Disease-induced changes in the plasma binding of basic drugs.

Authors:  K M Piafsky
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

Review 7.  Protein binding and kinetics of drugs in liver diseases.

Authors:  T F Blaschke
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

8.  Plasma protein binding of azapropazone in patients with kidney and liver disease.

Authors:  E Jähnchen; K J Blanck; K H Breuing; H J Gilfrich; T Meinertz; D Trenk
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

Review 9.  Clinical pharmacokinetics of dapsone.

Authors:  J Zuidema; E S Hilbers-Modderman; F W Merkus
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

10.  Plasma protein binding of valproic acid in healthy subjects and in patients with renal disease.

Authors:  R Gugler; G Mueller
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.